Certara, Inc. (NASDAQ:CERT) Receives Average Rating of “Hold” from Analysts

Shares of Certara, Inc. (NASDAQ:CERT) have received a consensus rating of “Hold” from the eleven analysts that are covering the company, Marketbeat Ratings reports. Seven research analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average 1-year target price among brokers that have covered the stock in the last year is $20.06.

CERT has been the topic of several research reports. UBS Group raised their price objective on shares of Certara from $17.00 to $20.00 and gave the company a “neutral” rating in a research report on Friday, March 1st. KeyCorp upgraded shares of Certara from a “sector weight” rating to an “overweight” rating and set a $23.00 price objective on the stock in a research report on Wednesday, April 10th. Leerink Partnrs restated a “market perform” rating on shares of Certara in a research report on Monday, February 26th. SVB Leerink initiated coverage on shares of Certara in a research report on Monday, February 26th. They set a “market perform” rating and a $19.00 price objective on the stock. Finally, Barclays raised their price objective on shares of Certara from $16.00 to $18.00 and gave the company an “equal weight” rating in a research report on Thursday, January 25th.

Certara Stock Performance

Shares of CERT stock opened at $16.45 on Thursday. The stock has a market capitalization of $2.64 billion, a P/E ratio of -47.00, a PEG ratio of 1.67 and a beta of 1.63. The company has a current ratio of 2.62, a quick ratio of 2.62 and a debt-to-equity ratio of 0.28. The firm’s 50 day moving average is $17.76 and its 200 day moving average is $16.22. Certara has a 12 month low of $11.81 and a 12 month high of $24.70.

Certara (NASDAQ:CERT) last posted its earnings results on Thursday, February 29th. The company reported $0.05 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.09 by ($0.04). Certara had a positive return on equity of 4.33% and a negative net margin of 15.62%. The firm had revenue of $88.01 million during the quarter, compared to analysts’ expectations of $86.80 million. On average, sell-side analysts anticipate that Certara will post 0.29 earnings per share for the current year.

Insider Activity at Certara

In related news, SVP Richard M. Traynor sold 6,000 shares of Certara stock in a transaction dated Monday, February 12th. The shares were sold at an average price of $18.00, for a total transaction of $108,000.00. Following the completion of the transaction, the senior vice president now directly owns 165,368 shares of the company’s stock, valued at approximately $2,976,624. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. In other Certara news, insider Patrick F. Smith sold 14,427 shares of Certara stock in a transaction dated Tuesday, April 2nd. The shares were sold at an average price of $16.85, for a total value of $243,094.95. Following the completion of the transaction, the insider now directly owns 50,091 shares of the company’s stock, valued at $844,033.35. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Richard M. Traynor sold 6,000 shares of Certara stock in a transaction dated Monday, February 12th. The stock was sold at an average price of $18.00, for a total transaction of $108,000.00. Following the completion of the transaction, the senior vice president now directly owns 165,368 shares of the company’s stock, valued at $2,976,624. The disclosure for this sale can be found here. Insiders sold a total of 23,427 shares of company stock valued at $405,095 in the last three months. Company insiders own 2.60% of the company’s stock.

Institutional Trading of Certara

A number of large investors have recently made changes to their positions in the stock. Mubadala Investment Co PJSC bought a new stake in Certara during the fourth quarter valued at approximately $169,135,000. Wasatch Advisors LP boosted its position in shares of Certara by 23.4% in the first quarter. Wasatch Advisors LP now owns 4,924,845 shares of the company’s stock worth $88,056,000 after purchasing an additional 932,598 shares during the period. Geneva Capital Management LLC boosted its position in shares of Certara by 29.0% in the fourth quarter. Geneva Capital Management LLC now owns 3,824,850 shares of the company’s stock worth $67,279,000 after purchasing an additional 860,763 shares during the period. Norges Bank bought a new position in shares of Certara in the fourth quarter worth approximately $14,262,000. Finally, Rathbones Group PLC bought a new position in shares of Certara in the third quarter worth approximately $11,007,000. 73.96% of the stock is currently owned by institutional investors.

Certara Company Profile

Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.